Basic Information
Nateglinide
55111-328
Regulatory Information
55111-328
ANDA077461
C73584
January 28, 2019
USA
These highlights do not include all the information needed to use NATEGLINIDE TABLETS safely and effectively. See full prescribing information for NATEGLINIDE TABLETS. NATEGLINIDE tablets, for oral use Initial U.S. Approval: 2000
HUMAN PRESCRIPTION DRUG LABEL
10
Company Information
650562841
Active Ingredients
Inactive Ingredients
silicon dioxide
Code: ETJ7Z6XBU4
Class Code: IACT
sodium lauryl sulfate
Code: 368GB5141J
Class Code: IACT
croscarmellose sodium
Code: M28OL1HH48
Class Code: IACT
mannitol
Code: 3OWL53L36A
Class Code: IACT
copovidone
Code: D9C330MD8B
Class Code: IACT
talc
Code: 7SEV7J4R1U
Class Code: IACT
sodium stearyl fumarate
Code: 7CV7WJK4UI
Class Code: IACT
carnauba wax
Code: R12CBM0EIZ
Class Code: IACT
starch, corn
Code: O8232NY3SJ
Class Code: IACT
Active Moieties
nateglinide
Code: 41X3PWK4O2